Travere Therapeutics, Inc. (TVTX) NASDAQ
42.96
-2.08(-4.62%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
42.96
-2.08(-4.62%)
Currency In USD
| Market Cap | 3.41B |
| Enterprise Value | 3.64B |
| P/E Ratio | -184.24 |
| PEG Ratio | -0.87 |
| Price/Sales Ratio | 7.45 |
| Price/Book Ratio | 39.98 |
| Enterprise/Revenue | 7.92 |
| Enterprise/EBITDA | 117.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.04 |
| Operating Margin | -0.11 |
| Return On Assets | -0.04 |
| Return On Equity | -0.27 |
| Revenue | 490.73M |
| Revenue/Share | 5.84 |
| Gross Profit | 480.39M |
| EBITDA | 22.22M |
| Net Income | -25.55M |
| Diluted EPS | -0.56 |
| Total Cash | 264.68M |
| Total Cash/Share | 2.88 |
| Total Debt | 327.66M |
| Total Debt/Equity | 3.32 |
| Current Ratio | 3.13 |
| Book Value Per Share | 1.07 |
| 52-Week Change | 178.96 |
| 52-Week High | 48.61 |
| 52-Week Low | 13.88 |
| Moving Average 50 Days | 38.9 |
| Moving Average 200 Days | 31.7 |
| Average Volume | 2.15M |
| Shares Outstanding | 92.99M |
| % Held by Institutions | 113.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | November 02, 2012 |